You are here

Imfinzi

AstraZeneca’s Imfinzi Phase III trial raises trial design questions

AstraZeneca’s Imfinzi Phase III trial raises trial design questions

Clinical Trials Arena

clinical trials

Flag link:

AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop

AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop

BioSpace

clinical trials

non-small cell lung cancer

Flag link:

AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial

AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial

Clinical Trials Arena

clinical trials

hepatocellular carcinoma

Flag link:

Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi

Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi

Fierce Pharma

biliary tract cancer

Flag link:

AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial

AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial

Biopharma Reporter

clinical trials

Flag link:

ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?

ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?

Fierce Pharma

Flag link:

AstraZeneca reports positive results from endometrial cancer therapy trial

AstraZeneca reports positive results from endometrial cancer therapy trial

Clinical Trials Arena

endometrial cancer

clinical trials

Flag link:

AstraZeneca's drug combo shows positive results in late-stage cancer trial

AstraZeneca's drug combo shows positive results in late-stage cancer trial

Reuters

endometrial cancer

Flag link:

AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate

AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate

Fierce Pharma

non-small cell lung cancer

Flag link:

AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer

AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer

Endpoints

clinical trials

Flag link:

AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial

AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial

Reuters

Flag link:

Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec

Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec

Fierce Pharma

non-small cell lung cancer

Flag link:

AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer

AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer

NASDAQ

biliary tract cancer

Flag link:

AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer

AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer

BioPharma Dive

clinical trials

non-small cell lung cancer

Flag link:

Here's What AstraZeneca's Recent FDA News Means for Shareholders

Here's What AstraZeneca's Recent FDA News Means for Shareholders

Motley Fool

Flag link:

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

Pharmaforum

biliary tract cancer

priority review

Flag link:

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono

AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono

Fierce Pharma

Ono Pharmaceutical

Flag link:

AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer

AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer

Pharmaforum

biliary tract cancer

clinical trials

Flag link:

AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer

AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer

NASDAQ

clinical trials

Flag link:

ESMO 2021 – Astra coasts towards a new lung cancer combo

ESMO 2021 – Astra coasts towards a new lung cancer combo

EP Vantage

non-small cell lung cancer

Flag link:

Pages